Efficacy of sunitinib and radiotherapy in genetically engineered mouse model of soft-tissue sarcoma.

[1]  F. McKeon,et al.  Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth. , 2008, Cancer cell.

[2]  S. Nie,et al.  Therapeutic Nanoparticles for Drug Delivery in Cancer Types of Nanoparticles Used as Drug Delivery Systems , 2022 .

[3]  C. Johannessen,et al.  TORC1 Is Essential for NF1-Associated Malignancies , 2008, Current Biology.

[4]  D. Hallahan,et al.  SU11248 (sunitinib) sensitizes pancreatic cancer to the cytotoxic effects of ionizing radiation. , 2007, International journal of radiation oncology, biology, physics.

[5]  G. Demetri,et al.  Molecular basis for sunitinib efficacy and future clinical development , 2007, Nature Reviews Drug Discovery.

[6]  N. Andratschke,et al.  Radiation therapy plus angiogenesis inhibition with bevacizumab: rationale and initial experience. , 2007, Reviews on recent clinical trials.

[7]  Jan Grimm,et al.  A spatially and temporally restricted mouse model of soft tissue sarcoma , 2007, Nature Medicine.

[8]  Vasilis Ntziachristos,et al.  Tomographic fluorescence imaging of tumor vascular volume in mice. , 2007, Radiology.

[9]  G. Parker,et al.  DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents , 2007, British Journal of Cancer.

[10]  P. Park,et al.  Angiogenic profile of soft tissue sarcomas based on analysis of circulating factors and microarray gene expression. , 2006, The Journal of surgical research.

[11]  M. Neeman,et al.  Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin. , 2006, Cancer cell.

[12]  D. Gutmann,et al.  Harnessing preclinical mouse models to inform human clinical cancer trials. , 2006, The Journal of clinical investigation.

[13]  N. Segal,et al.  Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A. , 2005, Cancer research.

[14]  D. Sahani,et al.  Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations. , 2005, Radiology.

[15]  Ricky T. Tong,et al.  Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer , 2004, Nature Medicine.

[16]  Jonathan R. Lindner,et al.  Imaging Tumor Angiogenesis With Contrast Ultrasound and Microbubbles Targeted to &agr;v&bgr;3 , 2003 .

[17]  Gerald McMahon,et al.  SU11248 maintenance therapy prevents tumor regrowth after fractionated irradiation of murine tumor models. , 2003, Cancer research.

[18]  A. Dicker,et al.  Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  Chun Xing Li,et al.  Tumor irradiation enhances the tumor-specific distribution of poly(L-glutamic acid)-conjugated paclitaxel and its antitumor efficacy. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[20]  W. Kruskal,et al.  Use of Ranks in One-Criterion Variance Analysis , 1952 .

[21]  D. Hume,et al.  Characterisation and trophic functions of murine embryonic macrophages based upon the use of a Csf1r-EGFP transgene reporter. , 2007, Developmental biology.

[22]  Jiri Sklenar,et al.  Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3. , 2003, Circulation.

[23]  Juthamas Sukbuntherng,et al.  In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[24]  S. Eidt,et al.  Cyclin-dependent kinase-inhibitor 1 (CDKN1A) in the squamous epithelium of the oropharynx: possible implications of molecular biology and compartmentation. , 2001, Anticancer research.